leadf
logo-loader
viewEMIS Group plc

EMIS expands diabetic eye screening business with new acquisition

agreement_greyscale350_54991eedad218.jpg

Healthcare services group EMIS (LON:EMIS) has unveiled the acquisition of Medical Imaging, a specialist in diabetic eye screening and ophthalmology imaging.

Medical Imaging is a contractor to the UK NHS and has a growing presence in Ireland’s national health service.

EMIS will pay £6.5mln cash upfront, and the acquisition cost could ultimately rise to £9.5mln.

Worcester-based Medical Imaging made a £1.3mln profit last year on £6.3mln of revenue, and EMIS expects the acquisition will be earnings enhancing in the first full year of ownership.

More than 90% of Medical Imaging’s revenue is recurring, EMIS said.

It added that the deal is complementary to the Digital Healthcare unit, acquired in 2013, and as such enhances services in an area closely aligned to its existing software systems.

EMIS chief executive Chris Spencer said: "I am delighted to welcome Medical Imaging to EMIS Group. It enhances our already strong position in diabetic eye screening, achieved through the 2013 acquisition of Digital Healthcare.

“This is a growing niche market.

“We expect the acquisition to be not only earnings enhancing in 2015 but also to help prevent blindness in the increasing number of people suffering from diabetes."

Quick facts: EMIS Group plc

Price: 992 GBX

AIM:EMIS
Market: AIM
Market Cap: £628.05 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

IXICO report double-digit revenue growth and a more than doubling of profit

IXICO PLC's (LON:IXI) CEO Giulio Cerroni joins Proactive London's Katie Pilbeam to discuss the financial results for the year which ended 30 September 2020.  Cerroni talks through the strong double-digit revenue growth and the more than doubling of profit.  He goes on to explain...

43 minutes ago

2 min read